eu.allelica.com
Open in
urlscan Pro
143.47.226.203
Public Scan
Submitted URL: https://cardioscore.eu/
Effective URL: https://eu.allelica.com/
Submission Tags: phishingrod
Submission: On August 14 via api from DE — Scanned from DE
Effective URL: https://eu.allelica.com/
Submission Tags: phishingrod
Submission: On August 14 via api from DE — Scanned from DE
Form analysis 1 forms found in the DOM
<form tag="form" class="contact-form">
<div class="contact-form__inputs"><label class="c-input contact-form__input subscription-form__input">
<div class="c-input__placeholder"><span class="c-input__placeholder-text"> First name * </span></div> <input name="name" type="text" class="c-input__input"> <!---->
</label> <label class="c-input contact-form__input subscription-form__input">
<div class="c-input__placeholder"><span class="c-input__placeholder-text"> Last name * </span></div> <input name="last_name" type="text" class="c-input__input"> <!---->
</label> <label class="c-input contact-form__input subscription-form__input">
<div class="c-input__placeholder"><span class="c-input__placeholder-text"> Email * </span></div> <input name="email" type="email" class="c-input__input"> <!---->
</label></div>
<div class="privacy-block"><input type="checkbox" id="checkbox"> <label for="checkbox" class="checkbox-message"> I confirm that I have read and agree to
<a href="/documents/allelica-privacy.pdf" target="_blank" style="color: rgb(70, 57, 202);">Allelica's Privacy Policy </a></label> <!----></div>
<div class="contact-form__footer subscription-form__footer">
<div data-sitekey="6LcY3V4dAAAAAGdKH3fsw8H9mwL5c7tyh2dIYt8U" data-size="normal" data-theme="light" data-badge="bottomright" data-tabindex="0" data-callback="recaptchaSuccessCallback" data-expired-callback="recaptchaExpiredCallback"
data-error-callback="recaptchaErrorCallback" class="g-recaptcha">
<div style="width: 304px; height: 78px;">
<div><iframe title="reCAPTCHA" width="304" height="78" role="presentation" name="a-8p8ekywniy2t" frameborder="0" scrolling="no"
sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-top-navigation allow-modals allow-popups-to-escape-sandbox allow-storage-access-by-user-activation"
src="https://www.recaptcha.net/recaptcha/api2/anchor?ar=1&k=6LcY3V4dAAAAAGdKH3fsw8H9mwL5c7tyh2dIYt8U&co=aHR0cHM6Ly9ldS5hbGxlbGljYS5jb206NDQz&hl=en&v=hfUfsXWZFeg83qqxrK27GB8P&theme=light&size=normal&badge=bottomright&cb=ygpqyayt4zww"></iframe>
</div><textarea id="g-recaptcha-response" name="g-recaptcha-response" class="g-recaptcha-response"
style="width: 250px; height: 40px; border: 1px solid rgb(193, 193, 193); margin: 10px 25px; padding: 0px; resize: none; display: none;"></textarea>
</div><iframe style="display: none;"></iframe>
</div> <!----> <br> <button type="submit" class="c-button contact-form__button subscription-form__button c-button--theme--filled"> JOIN </button>
</div> <!----> <!---->
</form>Text Content
Allelica's latest results on clinical multi-ancestry PRS published in Nature Communications → Clinical PRS Test Products PREDICT DISCOVER & VALIDATE Solutions Allelica Precision Server Corporate Health Resources PRS Clinical Academy Scientific publications & white papers Webinars Use cases Blog Videos Press releases About Team In the News Contact Us Login Menu Clinical PRS Test Products PREDICT DISCOVER & VALIDATE Solutions Allelica Precision Server Corporate Health Resources PRS Clinical Academy Scientific publications & white papers Webinars Use cases Blog Videos Press releases About Team In the News Contact Us Login EMPOWERING THE NEXT GENERATION OF CLINICAL GENOMICS Talk with us Allelica is a global life sciences company powering the healthcare and pharmaceutical industries with comprehensive solutions for the development and commercialization of clinical genetic tests. Uniquely positioned as innovators in genetic risk prediction and experts in medical devices, Allelica offers a cutting-edge quality management system, specifically designed to develop and implement new genetics based assays. WHAT WE DO SEAMLESS ASSAY DEVELOPMENT FOR CLINICAL GENETICS With an agile quality management system (QMS) built uniquely for clinical genetic tests, Allelica provides healthcare providers, biotechs and pharmaceutical companies with expertise and world class software for the development and validation of new genetic tests, from conception to commercialization. COMPREHENSIVE SOLUTIONS FOR POLYGENIC RISK SCORE TESTING Allelica is the leading provider of ancestry-specific clinical polygenic risk score testing in the US and Europe. SECURE & SCALABLE BIOINFORMATICS SOFTWARE Available as an on-premise or cloud-based solution, Allelica’s suite of digital tools enables laboratories to perform clinical PRS, Pharmacogenetics, and Carrier Screening analyses in-house. In addition to flexible software access options, Allelica offers multilingual, white label reporting for a range of our customizable PRS, PGx and CS panels. ALLELICA ISO CERTIFICATION TRUSTED BY "With this agreement, Merck confirms its strong commitment to advancing science and technology in the area of cardiovascular disease" Read more → Antonio Messina, General Manager, Merck Biopharma LATEST NEWS Allelica multi-ancestry PRS published in Nature Communications Results published by Allelica scientists in Nature Communications demonstrate the clinical utility of polygenic risk scores across multiple ancestry groups.The publication adds to growing evidence of the clinical value of PRS in cardiovascular disease risk assessment, showing that adding PRS to traditional models improves their precision and accuracy. Baylor & Allelica present clinical workflow for PRS testing at ASHG Allelica presented collaborative results with Baylor College of Medicine at the American Society of Human Genetics Annual Meeting 2023. George Busby, Allelica CSO, presented the results in the poster titled “Complete end-to-end workflow for implementing clinical polygenic risk scores”. Allelica launches the Allelica Precision Server Allelica announces the release of the Allelica Precision Server (APS) for CLIA-compliant, on-premises analysis and clinical reporting of polygenic risk score, pharmacogenomics and carrier screening. APS is now available for medical laboratories and healthcare providers. Allelica participates in BiotechX Europe 2023 The Allelica team met with leaders in the pharmaceutical industry and biotechnology at the annual BioTechX conference in Basel, Switzerland. PRS is increasingly gaining traction among pharma and biotech companies for its ability to stratify clinical trial populations and identify new drug targets. PRS cost-effectiveness results published in Frontiers Results published by Allelica researchers in Frontiers in Public Health reveal that integrating PRS testing into workplace health programs cuts costs for employers and improves quality of life for employees. Authors found that Allelica's workplace program integrating PRS with the standard of care, cardioriskSCORE, significantly outperformed programs without PRS. Allelica delivers oral presentation, three poster presentations at ESHG 2023 The Allelica team showcased exciting PRS results at the European Society of Human Genetics Conference 2023. Posters included: Low-coverage genotyping-by-sequencing with accurate long HiFi reads and optimized imputation (presented in collaboration with PacBio), Recalibrating polygenic risk scores to country-specific incidence, and Analyses of polygenic risk scores that consider individual-level admixture proportions outperform single ancestry approaches. Clinical breast cancer PRS Results presented at ASCO 2023 Dr. Daniel Morganstern of Hartford Healthcare presented results integrating Allelica’s multi-ancestry PRSs into risk assessments at the American Society of Clinical Oncology Annual Meeting. Findings revealed the value PRS provides in clinical risk assessments for breast cancer. Allelica Research Published in the Journal of the American Heart Association A health economics study [Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk‐Enhancing Factor in the Pooled Cohort Equation: A Cost‐Effectiveness Analysis Study] has been published in the Journal of the American Heart Association. The study, performed by Allelica, in collaboration with experts from Illumina and the University of Sydney, analyzed the cost-effectiveness of PRS in heart disease risk assessments and found that PRS is cost-saving in US health systems. Allelica CAD PRS Research in Circulation Allelica researchers identified a critical interaction between PRS for coronary artery disease (CAD) and LDL cholesterol level. Their discovery has major implications for clinical decision-making in primary prevention strategies. The research is now available in the American Heart Association Journal, Circulation. Allelica Obtains ISO Certification Allelica continues to set the industry standard of clinical-grade Polygenic Risk Score analysis with the addition of two key ISO certifications. ISO 13485 and ISO 9001 certify that Allelica applies medical device quality management processes every step of the way. OUR PRINCIPLES Data Driven Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality. Scientific Rigor We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way. Human-centricity Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life. Keep in touch! Leave your email to stay up-to-date with the latest advances in Polygenic Risk Score. First name * Last name * Email * I confirm that I have read and agree to Allelica's Privacy Policy JOIN X BIOINFORMATICS PRODUCTS PREDICT DISCOVER & VALIDATE SOLUTIONS Allelica Precision Server Corporate Health RESOURCES PRS Clinical Academy Scientific publications & white papers Webinars Use Cases Blogs Videos Press releases ABOUT US Team In the News Contact Us Privacy Policy Ⓒ 2024 Allelica, Inc. - All rights reserved